Cargando…
A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities
Inhibitors of the proteasome have been extensively studied for their applications in the treatment of human diseases such as hematologic malignancies, autoimmune disorders, and viral infections. Many of the proteasome inhibitors reported in the literature target the non-primed site of proteasome’s s...
Autores principales: | Wang, Juan, Liang, Boqiang, Chen, Yiling, Fuk-Woo Chan, Jasper, Yuan, Shuofeng, Ye, Hui, Nie, Linlin, Zhou, Jiao, Wu, Yi, Wu, Meixian, Huang, Lina S., An, Jing, Warshel, Arieh, Yuen, Kwok-Yung, Ciechanover, Aaron, Huang, Ziwei, Xu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873610/ https://www.ncbi.nlm.nih.gov/pubmed/33639344 http://dx.doi.org/10.1016/j.ejmech.2021.113267 |
Ejemplares similares
-
Potent inhibition of enterovirus D68 and human rhinoviruses by dipeptidyl aldehydes and α-ketoamides
por: Kim, Yunjeong, et al.
Publicado: (2016) -
Microwave irradiation: synthesis and characterization of α-ketoamide and bis (α-ketoamide) derivatives via the ring opening of N-acetylisatin
por: El-Faham, Ayman, et al.
Publicado: (2014) -
Computer modeling of chemical reactions in enzymes and solutions
por: Warshel, Arieh
Publicado: (1991) -
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
por: Chan, Jasper Fuk-Woo, et al.
Publicado: (2020) -
COVID-19: In silico identification of potent α-ketoamide inhibitors targeting the main protease of the SARS-CoV-2
por: Oubahmane, Mehdi, et al.
Publicado: (2021)